Drug Shortage Report for TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%
Report ID | 150632 |
Drug Identification Number | 02245522 |
Brand name | TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05% |
Common or Proper name | CLOBETASOL |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | CLOBETASOL PROPIONATE |
Strength(s) | 0.05% |
Dosage form(s) | SOLUTION |
Route of administration | TOPICAL TOPICAL |
Packaging size | 60ML |
ATC code | D07AD |
ATC description | CORTICOSTEROIDS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-11-16 |
Estimated end date | 2021-12-17 |
Actual end date | 2021-12-10 |
Shortage status | Resolved |
Updated date | 2022-01-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-01-06 | French | Compare |
v3 | 2022-01-06 | English | Compare |
v2 | 2021-12-07 | French | Compare |
v1 | 2021-12-07 | English | Compare |
Showing 1 to 4 of 4